Sitemap

November 08, 2016 Articles

Filter by Available Specialty
  1. ‘3+0’ schedule with PCV7 impacts IPD more than PCV13
  2. ALKS 5461 effective, safe for treatment-resistant MDD
  3. Analysis of the Canadian hypertension guidelines and the impact on upcoming recommendations
  4. Antenatal corticosteroids reduce respiratory distress syndrome in certain infants
  5. AUVI-Q to return in early 2017
  6. Avoid exaggeration in facial augmentation while creating natural symmetry
  7. Binge-eating risk increased with eating in the absence of hunger during childhood
  8. Cannabis potency may influence severity of dependence
  9. Carfilzomib-based triplet improves quality of life in relapsed multiple myeloma
  10. Conjugated linoleic acid improves insulin sensitivity
  11. Delayed HBV, HCV diagnosis may increase advanced liver disease
  12. Development of cholesterol efflux promoter discontinued
  13. Different neuromodulator filler products offer varied outcomes
  14. Endocrine disorders prevalent among childhood brain tumor survivors
  15. EOS Imaging receives FDA 510(k) clearance to market 3-D planning software for TKA
  16. FDA approves IND for elafibranor for primary biliary cholangitis
  17. FDA grants clearance to Syneron Candela's microneedling device for appearance of cellulite
  18. Fred Hutchinson Cancer Research Center names executive VP
  19. High failure rate found with use of modular-neck femoral stem in THA
  20. HIV-RNA common in spinal fluid of patients receiving ART
  21. Hypertensive disorders during pregnancy: A window into future CV risk
  22. Hypopituitarism, diabetes insipidus associated with decreased oxytocin, empathic ability
  23. Low FODMAP diet improves IBS-D symptoms
  24. Maternal B12 levels associated with leptin levels in placental tissue, cord blood
  25. Maternal return-to-work timing linked to child’s weight gain
  26. New questionnaire more accurately identified rheumatic disease
  27. One in five C. diff patients re-hospitalized within 30 days
  28. PrEP regimens containing Selzentry safe, well-tolerated compared with Truvada
  29. Prescription subsidies reduce racial disparities in hormone therapy persistence
  30. pSivida brings on Deb Jorn as executive vice president of corporate and commercial development
  31. Quantitative MRI study finds chondroitin sulfate superior to celecoxib for knee cartilage loss
  32. Quantity limits for blood glucose test strips reduce costs
  33. Spark Therapeutics reports $32.6 million loss in third quarter
  34. Study challenges the causal interpretation of childhood abuse, cognitive function
  35. Study finds brain changes may still occur in youth football players exposed to sub-concussive impact
  36. SVOne comparable to traditional refractive error measures
  37. Tailored dose-dense therapy fails to improve RFS in early breast cancer
  38. The 5 most-viewed articles by Cardiology Today’s Intervention readers in October
  39. Trial Scorecard: CALIBER
  40. Trial Scorecard: DANISH
  41. Trial Scorecard: DISRUPT PAD
  42. Trial Scorecard: ESPRIT I
  43. Trial Scorecard: INTERHEART
  44. Trial Scorecard: ROPAC
  45. Trial Scorecard: TACTICS-HF
  46. Trial Scorecard: TARIFF
  47. Triggered vaccination campaigns could reduce size, severity of measles outbreaks
  48. USPSTF colorectal cancer screening guidelines challenged
  49. Venomous copperhead, exotic snakebites on the rise among children
  50. VIDEO: PRK an acceptable option for thin corneas
  51. VIDEO: Treat astigmatism in glaucoma patients at time of cataract surgery
  52. VIDEO: Trial of embolic protection during TAVR confirms need for further study
  53. Wearable technologies may transform patient care, clinical research